Duodenoscope makers ordered to study device-cleaning processes

By Steven Ross Johnson  |  October 05, 2015

Federal regulators Monday ordered makers of some duodenoscopes to conduct post-market research on how disinfecting those devices works in medical settings. The move is in response to several recent outbreaks of antibiotic-resistant infections due to the scopes.

FDA will destroy banned imported drugs

By Steven Ross Johnson  |  September 30, 2015

Federal regulators will begin destroying some medications that ​can't be imported into the U.S.​ because of quality concerns. The FDA says the new process will allow them to focus its limited resources.

Heart attack care and outcomes are worse for women

By Sabriya Rice  |  September 29, 2015

Women receive significantly fewer aggressive treatments after a heart attack than men despite the fact that a greater percentage of women die from the events. Researchers say gender differences will play a greater role as healthcare moves toward an era of personalized or precision medicine.

Airport scanners don't overradiate passengers, report says

By Sabriya Rice  |  September 29, 2015

Backscatter machines previously used in U.S. airports to check passengers for potential threats don't expose passengers to too much radiation, according to a report released Tuesday. The 148-page report comes as the Transportation Security Administration considers a second-generation model that...

UPMC reopens transplant program after mold investigation

By Associated Press  |  September 27, 2015

A Pittsburgh-area medical system is re-opening its organ transplant program, six days after closing it because of concerns that mold contributed to the deaths of three transplant patients who had fungal infections.

Editorial: Diagnosing Wisely

Editorial: Diagnosing Wisely

By Merrill Goozner  |  September 26, 2015

Despite its title, “Improving Diagnosis in Health Care,” you have to dig deep into the Institute of Medicine's first-ever report on the problem of misdiagnosed patients to find proposals that will have an immediate impact on the problem.

Post-market surveillance must ramp up to flag adverse events

By Sabriya Rice  |  September 25, 2015

During a Food and Drug Administration hearing Thursday to scrutinize the safety and efficacy of the Essure female contraceptive, Essure's maker, Bayer, revealed it had received more than 17,000 adverse-event reports from women around the globe.

Not enough research means Essure use should be limited

By Virgil Dickson  |  September 24, 2015

A panel of independent experts Thursday told the U.S. Food and Drug Administration that not enough research was done to prove the safety of a permanent female sterilization device it approved 13 years ago, and that it should limit its use. Activists wanted Essure pulled from the market.

Generic drugs are potentially high-priced apples, ripe for the picking

By Steven Ross Johnson  |  September 23, 2015

A pharmaceutical company's move to raise the price of a generic drug by more than 5,000% has some pointing to the lack of regulation over the market. Experts say companies are acquiring generics to drive up their prices and can do that because there aren't many competitors.

Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.